↓ Skip to main content

Amphetamines for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Amphetamines for schizophrenia
Published in
Cochrane database of systematic reviews, July 2004
DOI 10.1002/14651858.cd004964
Pubmed ID
Authors

Sue Nolte, David Wong, Gary Latchford, Owen Boyle, Adaeze Anaenugwu

Abstract

It is estimated that between 10% and 65% of people with schizophrenia use illicit drugs such as amphetamines. This group have an increased rate of hospitalisation, homelessness, unemployment and suicide compared with those with schizophrenia who do not abuse drugs.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 <1%
Canada 1 <1%
Brazil 1 <1%
Unknown 103 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 13%
Student > Master 14 13%
Student > Bachelor 13 12%
Student > Doctoral Student 13 12%
Student > Ph. D. Student 12 11%
Other 22 21%
Unknown 18 17%
Readers by discipline Count As %
Medicine and Dentistry 34 32%
Psychology 18 17%
Nursing and Health Professions 11 10%
Social Sciences 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 9 8%
Unknown 22 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2016.
All research outputs
#2,966,352
of 12,343,748 outputs
Outputs from Cochrane database of systematic reviews
#4,672
of 8,434 outputs
Outputs of similar age
#27,549
of 123,561 outputs
Outputs of similar age from Cochrane database of systematic reviews
#33
of 82 outputs
Altmetric has tracked 12,343,748 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,434 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.9. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,561 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.